MedTrace Logo

Performance Evaluation of Dream OCT: AP Study

NCT07355491 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2026-07-29

No results posted yet for this study

Summary

This study will evaluate the clinical performance of a new swept-source OCT imaging device, the VG200D, and to evaluate substantial equivalence with a predicate device, the Cirrus 5000. Clinical performance will be assessed through an agreement and precision analysis of OCT measurement parameters.

Conditions

  • Glaucoma Patients
  • Retina Patients
  • Eyes With Corneal Abnormality
  • Normal Healthy Eyes

Interventions

DEVICE

This is an observational study only, all patients are imaged on the investigational device

This study is a non-significant risk study where enrolled patients are imaged on an investigational device and a predicate device

Sponsors & Collaborators

  • Illinois College of Optometry

    collaborator OTHER

  • Intalight, Inc

    lead INDUSTRY

Principal Investigators

  • Micahel Chaglasian, OD · Illinois College of Optometry

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-16
Primary Completion
2026-05-12
Completion
2026-05-12
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07355491 on ClinicalTrials.gov